The purpose of this article is to provide an overview of latent class analysis (LCA) and examples from symptom cluster research that includes biomarkers and genetics. A review of LCA with genetics and biomarkers was conducted using Medline, Embase, PubMed, and Google Scholar. LCA is a robust latent variable model used to cluster categorical data and allows for the determination of empirically determined symptom clusters. Researchers should consider using LCA to link empirically determined symptom clusters to biomarkers and genetics to better understand the underlying etiology of symptom clusters. The full potential of LCA in symptom cluster research has not yet been realized because it has been used in limited populations, and researchers have explored limited biologic pathways.
occur together. They may or may not share the same etiology (Fan, Filipczak, & Chow, 2007) . Several statistical methods have been used to determine symptom clusters, including correlations, factor analysis, principal components analysis, cluster analysis, and latent class analysis (LCA; Kim, Abraham, & Malone, 2013) . There is not an ideal statistical method for identifying symptom clusters, the choice of a statistical method must be carefully considered and based on the research question and the theoretical foundation of the study (Kim et al., 2013; Maliski, Kwan, Elashoff, & Litwin, 2008) .
LCA is a robust categorical statistical method that is well suited to answer many questions pertinent to nursing and symptom cluster research (Kim et al., 2013) . LCA allows researchers to empirically determine symptom clusters. LCA has recently gained attention and use in social science research (Lanza & Rhoades, 2013) . However, LCA has been largely overlooked by nurse researchers for more familiar clustering techniques, such as factor analysis, cluster analysis, and structural equation modeling, even when LCA is better suited to answer the proposed research questions (Berlin, Williams, & Parra, 2014; Hagenaars & McCutcheon, 2002) .
Medline, Embase, PubMed, and Google Scholar were searched to find publications that provide guidance for using LCA and examples of LCA being used in symptom cluster research. The reference lists from the relevant publication also were reviewed to uncover additional publications. An overview of LCA is presented, and examples from symptom cluster research that includes biomarkers and genetics are presented as well.
Latent Class Analysis
There are two conceptual views of symptom clusters: the grouping of variables (variable-oriented) and the grouping of people (person-oriented) (Maliski et al., 2008) . A variable-oriented approach focuses on identifying relationships between variables, and it is assumed that these relationships are stable across the population. Traditional factor analysis is an example of a variable-oriented clustering approach, and it is useful to explore relationships in homogeneous populations (Bergman & Trost, 2006; Collins & Lanza, 2010) . In contrast, a person-oriented approach identifies subgroups of people who exhibit similar patterns of characteristics. LCA is an example of a person-oriented approach (Collins & Lanza, 2010) . A person-oriented approach is particularly useful to uncover subgroups in heterogeneous populations (Magnusson, 2003) . The use of variable-oriented versus person-oriented approaches allows for different statements to be made; thus, the selection of which approach to use is determined by the research questions and the theoretical foundation (Bergman & Trost, 2006; von Eye, Bogat, & Rhodes, 2006) . The rest of this article will focus on the use of a person-oriented approach, LCA.
LCA is a categorical statistical technique that is used to identify subgroups or classes of individuals based on response patterns in a set of categorical data (Collins & Lanza, 2010; Goodman, 1974; Lazarsfeld & Henry, 1968) . These subgroups or classes are latent variables. Latent variables are unmeasured and unobserved variables, which are interfered from observed variables (indicator variables) using statistical methods (Bollen, 2002) . The main assumption of latent variables is that of local independence, where it is assumed that observed variables are only connected through the latent variable (Bollen, 2002) . This assumption refers only to conditioning on the latent variable and does not imply that the indicator variables in the data set are independent. It is expected that the indicators would be correlated in the overall sample (Collins & Lanza, 2010) . In symptom cluster research, the latent variables are symptom clusters, which are inferred from observed symptoms that are measured using validated symptom measures.
LCA discerns meaningful latent classes against background noise and provides a way to arrange complex data in a parsimonious manner (Collins & Lanza, 2010) . For example, when using LCA for symptom clusters, LCA identifies groups of people who have a similar symptom experience. LCA has been successfully used to determine symptom cluster membership in various patient populations, including myocardial infarction (Ryan et al., 2007) , cancer (Doong et al., 2015; Illi et al., 2012) , and the menopause transition (Woods, Cray, Mitchell, & Herting, 2014) .
Selecting Indicator Variables
Symptoms that could be used in LCA are diverse but may include sleep disturbance, pain, fatigue, depression, anxiety, abdominal bloating, itching, and so on. The selection of indicators in an LCA model should be based on the empiric literature and guided by theory. (See Table 1 for examples of indicator variables used in symptom cluster research.) When selecting indicator variables, it has been suggested that using no less than five indicator variables may help with model convergence (Wurpts & Geiser, 2014) . However, some researchers also have suggested that using a limited number of indicator variables may assist with interpretability, help with classification, and increase accuracy of parameter estimates (Dean & Raftery, 2010) .
In LCA, there are no assumptions regarding the normal distribution of the indicator variables (McCutcheon, 1987) . Data suitable for LCA include binary, categorical, Likert-type scale, or nominal data (Vermunt & Magidson, 2004) . LCA cannot be used with purely ordinal data (Collins & Lanza, 2010;  Lanza, Collins, Lemmon, & Schafer, 2007) . If indicators are continuous, they need to be reduced into meaningful categorical data for LCA, or latent profile analysis, a variation of LCA that allows for the use of continuous indicator variables, can be used (Vermunt & Magidson, 2002) . Due to the need for categorical variables, using symptom measures with established cutoff scores is useful so that the presence/absence of a symptom is clear and clinically meaningful.
Model Selection
The number of latent classes in the final model is determined by a combination of statistical criteria, parsimony and interpretability (Lanza & Collins, 2008) . To determine the final model, the researcher runs models with different numbers of classes, is determined by relative fit statistics, where fit is compared between models (Nylund, Asparouhov, & Muthén, 2007) . Common fit statistics used to determine what number of latent classes better represent the data are the Akaike information criterion (AIC; Akaike, 1987) and the Bayesian information criterion (BIC; Goodman, 1974) . For both of these statistics, both lower numbers indicate better fit.
Parameter Estimates
In LCA, two sets of parameters are estimated: (a) prevalence of each latent class and (b) conditional response probabilities or the probability that each indicator is present/absent for members of the latent class. In LCA, subjects are classified into groups that are mutually exclusive and exhaustive, meaning that each individual is assigned to one group, but only one group, thus, latent class prevalences sum to 100 (Collins & Lanza, 2010) . Individuals are classified into latent classes based on probability. Item-response probabilities range from 0 to 1, with 1 meaning that conditional membership in a latent class is certain and 0 meaning that there is independence between the indicator variable and the class (Lanza et al., 2007) . The interpretation and labeling of latent classes are done by the researcher and are based on the item-response probabilities (Vermunt & Magidson, 2002) .
Sample Size Requirements
LCA requires a large sample size. In general, larger sample sizes provide better model estimation; thus, researchers have suggested that a minimum sample size of 100 to 300 is optimal to ensure an optimal model (Collins & Lanza, 2010; Wurpts & Geiser, 2014) . For additional guidance on power and sample size, Dziak, Lanza, and Tan (2014) published power tables to guide sample size selection in LCA.
Statistical Software
Currently, LCA is not included in standard statistical packages. Free downloadable add-ons for SAS, Stata, and R are available from the Methodology Center at Pennsylvania State University (http://methodology.psu.edu/downloads). Other examples of packages that can be used to perform LCA include Latent GOLD (Vermunt & Magidson, 2000) , Mplus (Muthén & Muthén, 1998 , and PANMARK3 (Van de Pol, Langeheine, & de Jong, 1998). Each software package uses slightly different language and fit statistics, so it is important to become familiar with the package that you are planning to use.
Extensions of LCA
Many research questions regarding symptom clusters extend beyond just determining symptom clusters at one time point. Many extensions of LCA allow LCA to be useful in answering diverse research questions about how symptom cluster groups differ and how symptom cluster membership changes over time. Multiple-group LCA allows the researcher to explore whether there are group differences between the latent group prevalences and itemresponse probabilities where the groups are observed groups (e.g., gender, anemia; Collins & Lanza, 2010) . LCA with covariates uses a logistic link function to identify characteristics, such as age, gender, or biomarkers, to predict symptom cluster membership (Collins & Lanza, 2010; Lanza et al., 2007) . Latent transition analysis is a longitudinal extension of LCA that addresses the factor of time and allows for the modeling of changes in symptom cluster membership over two or more time periods (Roberts & Ward, 2011) . Using the extensions of LCA greatly increases one's ability to answer pertinent nursing questions but can make the interpretation of the results complex. As such, support from a statistician familiar with latent class modeling for more complex analysis is needed. See Table 1 for examples of LCA with biomarkers and genetics.
Examples of LCA in the Symptom Cluster Literature
In addition to identifying empirically determined symptom clusters, the linking of symptom clusters to biomarkers, genetics, and epigenetics is essential to understanding the underlying etiology of symptom clusters (Cleeland et al., 2003) . The use of biomarkers in symptom cluster research has the potential to assist in identifying who is at risk for experiencing a high symptom burden and treatment responders and nonresponses . In LCA, biomarkers and genetic information could be used as covariates, indicator variables, or as a grouping variable to assist with uncovering the etiology of symptom clusters.
Biomarkers and Genetics as Indicator Variables
Researchers can use LCA to cluster biomarkers and genetic variables, along with the symptoms, as indicator variables. There is limited research that includes biological variables as an indicator variable. Although not specific to symptom clusters, one study in asthma used symptoms and demographic, clinical, and biomarker variables as indicator variables and found interpretable and clinically relevant latent clusters (Siroux et al., 2011) . Other authors have suggested that including signs, symptoms, and biomarkers as indicator variables in LCA may provide improved case detection (Sood & Ford, 2015) . However, a lack of clear clinical cutoff points may limit the use of adding biomarkers as indictor variables in LCA, as LCA requires the use of categorical indicator variables. Latent profile analysis, a variation of LCA that allows for the use of continuous indicator variables (Berlin et al., 2014) , may be more appropriate to use when adding biomarkers as an indicator variable.
Biomarkers and Genetics as Multiple-Group Variable
Biomarker and genetic variables can be included as a grouping in multiple-group LCA to compare LCA structure across groups. Biomarkers with established cutoff scores lend themselves to this type of analysis because distinct existing groups are needed to conduct multiple-group LCA. However, many novel biomarkers do not have clear cutoff points of what is considered "normal/abnormal," which limits the use of multiple-group LCA. An example of a biomarker that could be used in multiple-group LCA is hemoglobin/hematocrit with groups of anemic and nonanemic to compare differences in latent class symptom cluster membership across the two groups. Another limitation to using a gene or a biomarker as a grouping variable in multiple-group LCA is that the researcher can only use one polymorphism or biomarker to compare classes by groups.
Biomarkers and Genetics as Covariates
In LCA with covariates, a logistic or multinomial regression is performed to explore associations between biomarkers or genetic variables with symptom cluster membership. Both categorical and continuous covariates can be used in LCA with covariates. LCA with covariates has been used to identify associations between biomarker or genetic variables and symptom cluster membership in diverse populations, including cancer (Doong et al., 2015; Illi et al., 2012) , the menopause transition (Lamers et al., 2013) , and depressive symptoms (Woods et al., 2014) . Two studies explored how pro-inflammatory genetic polymorphisms are associated with symptom cluster membership in cancer (Doong et al., 2015; Illi et al., 2012) . The researchers found that there were genetic polymorphisms in the following pro-inflammatory cytokine genes, which were associated with membership in the all-high symptom class compared with the all-low symptom class, interleukin 6 (IL-6), IL-13, tumor necrosis factoralpha (Doong et al., 2015) , and IL-4 (Illi et al., 2012) .
Another study explored hypothalamic-pituitary-ovarian axis (HPO), hypothalamic-pituitary-adrenal axis (HPA), and autonomic nervous system biomarkers in menopause transition and early menopause (Woods et al., 2014) . The researchers found associations between low estrogen, high follicle-stimulating hormone, low epinephrine, and low norepinephrine with membership in the low symptom severity group compared with the high symptom severity group.
A fourth study explored metabolic, inflammatory, and HPA-axis biomarkers associated with depressive symptom cluster membership (Lamers et al., 2013) . The researchers suggest that atypical and melancholic depression have distinct biomarkers as atypical depression is associated with increased metabolic and inflammatory biomarkers, and melancholic depression is associated with HPA-axis biomarkers.
As demonstrated in the above studies, a benefit of using LCA with covariates with genetic and biomarker data is that it allows for the use of multiple genetic polymorphisms and biomarkers to determine the association with symptom cluster membership. The identification of multiple genetic polymorphisms and biomarkers may allow for the discovery of a common etiology in symptom clusters, as common pathways may be implicated in symptom cluster membership. However, to date, research is limited in connecting symptom clusters to genetics and biomarkers, and the further research is needed to better understand the etiology of symptom clusters.
Discussion
LCA allows researchers to connect biomarkers and genetics to empirically validated symptom clusters. The results of these few studies that have used LCA with genetics and biomarkers are encouraging and support the idea that symptom clusters have a common etiology. However, the full potential of LCA in symptom cluster research has not been realized, as it has been used in limited populations and explored limited pathways. Other common mechanisms that researchers should consider exploring with symptom clusters determined by LCA include inflammatory cytokines (Cleeland, 2007) , genetic polymorphisms and genetic expression of inflammatory pathways (Starkweather et al., 2013) , and the microbiota-gut-brain axis (Mayer, Tillisch, & Gupta, 2015; Montiel-Castro, Gonzalez-Cervantes, Bravo-Ruiseco, & Pacheco-Lopez, 2013) . Research linking biologic pathways and symptom clusters may eventually provide knowledge about personalized symptom risk profiles needed to create tailored symptom management interventions and improve patient outcomes (Starkweather et al., 2013) .
There are several strengths of using LCA in symptom cluster research. Using LCA with biomarkers and genetics data allows researchers to connect biomarkers and genetics to empirically determined symptom clusters. Also, LCA is data-driven, and thus, no hypotheses about the interaction of the indicators are needed to perform LCA (Collins & Lanza, 2010) . Because no hypothesis is needed, LCA is particularly useful in situations where little is known about the phenomena, which is frequently the case in symptom cluster research. In addition, LCA provides robust model fit statistics, which provides confidence in model selection and allows for the stability of the findings in subgroups to be tested (Berlin et al., 2014; Collins & Lanza, 2010) .
Another strength of LCA is that it does not have any assumptions of normality. Because LCA does not require normally distributed data it makes LCA well suited for use with a variety of data where assumptions of multivariate normality may not be able to be met, including administrative databases and previously collected data (Magidson & Vermunt, 2003) . However, LCA, as with any statistical method, cannot overcome measurement or collection errors in symptoms, genetics of biomarker data, which may be an issue in preexisting data.
The major limitation of LCA is the need for a large sample size. This requirement can be difficult to meet in research that uses biomarkers and genetic information due to the cost of data collection processing for researchers (Mayeux, 2004) . Another limitation in LCA is that complex latent class models require statistical expertise to run and interpret. Researchers without expertise in this method should ensure they have statistical support before starting a study. Additional studies are needed that explore symptom clusters and biomarker and genetic variables to determine the full strengths and limitations of LCA in this research.
The use of LCA in conjunction with biomarkers and genetics has the potential to expand our knowledge about the underlying etiology of symptom clusters and to allow for early detection, diagnosis, and treatment of symptoms. Potentially, people at the greatest risk of high symptom burden can be identified and treated early, thus preventing long-term sequela of untreated symptoms .
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